Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive factors of achieving therapeutic goals of hypertriglyceridemia.
Pintó X, Valdivielso P, Perez de Juan JM, Plana N, Garcia-Arias C, Fuentes FJ, Hernández-Mijares A, Mostaza JM; Spanish Registry of Hypertriglyceridemia (Spanish Society of Arteriosclerosis, SAS). Pintó X, et al. Among authors: mostaza jm. Curr Med Res Opin. 2014 Jan;30(1):19-26. doi: 10.1185/03007995.2013.850069. Epub 2013 Oct 18. Curr Med Res Opin. 2014. PMID: 24083660
[Lower limb arterial disease and renal artery stenosis].
Guijarro C, Mostaza JM, Hernández-Mijares A. Guijarro C, et al. Among authors: mostaza jm. Clin Investig Arterioscler. 2013 Nov-Dec;25(5):218-23. doi: 10.1016/j.arteri.2013.10.002. Epub 2013 Nov 14. Clin Investig Arterioscler. 2013. PMID: 24238748 Spanish.
[LDL-cholesterol control in patients with genetic dyslipidemia followed up by Lipid and Vascular Risk Units of the Spanish Society of Arteriosclerosis].
Lahoz C, Mostaza JM, Pintó X, de la Cruz JJ, Banegas JR, Pedro-Botet J; grupo de investigadores EDICONDIS-ULISEA. Lahoz C, et al. Among authors: mostaza jm. Clin Investig Arterioscler. 2015 Jan-Feb;27(1):1-8. doi: 10.1016/j.arteri.2014.04.001. Epub 2014 Jun 2. Clin Investig Arterioscler. 2015. PMID: 24882148 Spanish.
Atherogenic dyslipidemia: prevalence and management in lipid clinics.
Pedro-Botet J, Flores-Le Roux JA, Mostaza JM, Pintó X, de la Cruz JJ, Banegas JR; en nombre del grupo de investigadores EDICONDIS-ULISEA. Pedro-Botet J, et al. Among authors: mostaza jm. Rev Clin Esp (Barc). 2014 Dec;214(9):491-8. doi: 10.1016/j.rce.2014.06.001. Epub 2014 Jul 9. Rev Clin Esp (Barc). 2014. PMID: 25016414 English, Spanish.
Standards for global cardiovascular risk management arteriosclerosis.
Mostaza JM, Pintó X, Armario P, Masana L, Ascaso JF, Valdivielso P; en nombre de la Sociedad Española de Arteriosclerosis; Miembros de la Sociedad Española de Arteriosclerosis. Mostaza JM, et al. Clin Investig Arterioscler. 2019 Jul;31 Suppl 1:1-43. doi: 10.1016/j.arteri.2019.03.004. Epub 2019 Apr 11. Clin Investig Arterioscler. 2019. PMID: 30981542 Free article. English, Spanish.
Indications of PCSK9 inhibitors in clinical practice. Recommendations of the Spanish Sociey of Arteriosclerosis (SEA), 2019.
Ascaso JF, Civeira F, Guijarro C, López Miranda J, Masana L, Mostaza JM, Pedro-Botet J, Pintó X, Valdivielso P. Ascaso JF, et al. Among authors: mostaza jm. Clin Investig Arterioscler. 2019 May-Jun;31(3):128-139. doi: 10.1016/j.arteri.2019.04.002. Epub 2019 May 24. Clin Investig Arterioscler. 2019. PMID: 31130361 Free article. English, Spanish.
150 results